Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study

Miklos DB, Abu Zaid M, Cooney JP, Albring JC, Flowers M, Skarbnik AP, Yakoub-Agha I, Ko BS, Bruno B, Waller EK, Yared J, Sohn SK, Bulabois CE, Teshima T, Jacobsohn D, Greinix H, Mokatrin A, Lee Y, Wahlstrom JT, Styles L, Socie G. (2023)

In: Journal of Clinical Oncology, 41(10).

Forschungsartikel (Zeitschrift)

First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study

Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020)

In: Cancers, 12(6).

Forschungsartikel (Zeitschrift)

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation

Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017)

In: Bone Marrow Transplantation, 52(2).

Forschungsartikel (Zeitschrift)

Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor

Grajales-Reyes GE, Iwata A, Albring J, Wu X, Tussiwand R, Kc W, Kretzer NM, Briseño CG, Durai V, Bagadia P, Haldar M, Schönheit J, Rosenbauer F, Murphy TL, Murphy KM (2015)

In: Nature Immunology, 16(7).

Forschungsartikel (Zeitschrift)

Publikationen

Kontakt

Top-Links

Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study Miklos DB, Abu Zaid M, Cooney JP, Albring JC, Flowers M, Skarbnik AP, Yakoub-Agha I, Ko BS, Bruno B, Waller EK, Yared J, Sohn SK, Bulabois CE, Teshima T, Jacobsohn D, Greinix H, Mokatrin A, Lee Y, Wahlstrom JT, Styles L, Socie G. (2023) In: Journal of Clinical Oncology, 41(10). Forschungsartikel (Zeitschrift)
18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD) Roll W, Schindler P, Masthoff M, Strotmann R, Albring J, Reicherts C, Weckesser M, Noto B, Stelljes M, Schäfers M, Evers G. (2021) In: BMC Cancer, 21(1). Forschungsartikel (Zeitschrift)
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020) In: Cancers, 12(6). Forschungsartikel (Zeitschrift)
Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation Robert S, Albring JC, Frebel K, Opitz C, Urh J, Wolf C, Heinrich C, Berdel WE, Stelljes M (2018) In: Bone Marrow Transplantation, 53(7). Forschungsartikel (Zeitschrift)
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017) In: Bone Marrow Transplantation, 52(2). Forschungsartikel (Zeitschrift)
Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT Sauer T, Silling G, Groth C, Rosenow F, Krug U, Gorlich D, Evers G, Albring J, Besoke R, Mesters RM, Muller-Tidow C, Kessler T, Buchner T, Berdel WE, Stelljes M (2015) In: Bone Marrow Transplantation, 50(4). Forschungsartikel (Zeitschrift)
Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor Grajales-Reyes GE, Iwata A, Albring J, Wu X, Tussiwand R, Kc W, Kretzer NM, Briseño CG, Durai V, Bagadia P, Haldar M, Schönheit J, Rosenbauer F, Murphy TL, Murphy KM (2015) In: Nature Immunology, 16(7). Forschungsartikel (Zeitschrift)